The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
NF-κB signaling and bone resorption
Open accessAbstract
The transcription factor NF-κB is a family of proteins involved in signaling pathways essential for normal cellular functions and development. Deletion of various components of this pathway resulted with abnormal skeletal development. Research in the last decade has established that NF-κB signaling mediates RANK ligand-induced osteoclastogenesis. Consistently, it was shown that inhibition of NF-κB was an effective approach to inhibit osteoclast formation and bone resorptive activity. Identification of the molecular machinery underlying NF-κB activation permitted osteoclast-specific deletion of the major components of this pathway. As a result, it was clear that deletion of members of the proximal IKK kinase complex and the distal NF-κB subunits and downstream regulators affected skeletal development. These studies provided several targets of therapeutic intervention in osteolytic diseases. NF-κB activity has been also described as the centerpiece of inflammatory responses and is considered a potent mediator of inflammatory osteolysis. Indeed, inflammatory insults exacerbate physiologic RANKL-induced NF-κB signals leading to exaggerated responses and to inflammatory osteolysis. These superimposed NF-κB activities appear to underlie several bone pathologies. This review will describe the individual roles of NF-κB molecules in bone resorption and inflammatory osteolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 2×
“With the discovery of the RANK/RANKL signaling system in the late 1990s [16, 17], the critical pieces of the NF-κB puzzle pertaining to osteoclast differentiation and”
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701 · cited 2×
“of c-Fos deficiency [81, 88].”
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Structure, Regulation and Function of NF-kappaB
Siebenlist, U., Franzoso, G., & Brown, K. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,075
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M., Mann, M., Manning, A., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,040
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767 · cited 1×
“had beneficial effects on bone health [96–103].”
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · cited 1×
“inflammation in multiple organs, owing to hyper-activation of IKK and NF-κB signaling [75].”
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science's STKE · doi:10.1126/stke.3572006re13 · Cited by 1,274
IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK
Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., & Goeddel, D. V. (1997) · Science · doi:10.1126/science.278.5339.866 · Cited by 1,181
Identification and Characterization of an IκB Kinase
Régnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z., & Rothe, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80344-x · Cited by 1,174
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119 · cited 1×
“function are mostly in place [18–21].”
Requirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Tokunaga, F., Sakata, S.-I., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1821 · Cited by 942
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Chen, Z. J., & Sun, L. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.014 · Cited by 923
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051150 · Cited by 849
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Döffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S., et al. (2001) · Nature Genetics · doi:10.1038/85837 · Cited by 828
Hicke, L., Schubert, H. L., & Hill, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1701 · Cited by 794
Inflammation and Bone Loss in Periodontal Disease
Cochran, D. L. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080233 · Cited by 732
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Cited by 650
TRANCE, a TNF Family Member, Activates Akt/PKB through a Signaling Complex Involving TRAF6 and c-Src
Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H., & Choi, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80232-4 · Cited by 592
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P. A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23417 · Cited by 576
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Abu-Amer, Y., Darwech, I., & Clohisy, J. C. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2170 · Cited by 534
Self-citationBcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527
Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
Matsuo, K., Galson, D. L., Zhao, C., Peng, L., Laplace, C., Wang, K. Z. Q., Bachler, M. A., Amano, H., Aburatani, H., Ishikawa, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313973200 · Cited by 501
Blocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
NF-κB Activation: The IκB Kinase Revealed?
Stancovski, I., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80413-4 · Cited by 492
Mundy, G. R. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00353.x · Cited by 478
Ubiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 457
Zandi, E., Chen, Y., & Karin, M. (1998) · Science · doi:10.1126/science.281.5381.1360 · Cited by 454
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444 · cited 1×
“Like CYLD, A20 is a potent inhibitor of IKK and a target gene of NF-κB [73, 74].”
The atypical PKC-interacting protein p62 channels NF-kappa B activation by the IL-1-TRAF6 pathway
Sanz, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1576 · Cited by 436
Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I. R., Schwarz, E. M., Takeshita, S., Wagner, E. F., Noda, M., Matsuo, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610701200 · Cited by 408
Mundy, G. R. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s147-s151 · Cited by 406
Transcription factor cross-talk: the estrogen receptor and NF-κB
Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388
The Cellular and Molecular Biology of Periprosthetic Osteolysis
Purdue, P. E., Koulouvaris, P., Potter, H. G., Nestor, B. J., & Sculco, T. P. (2007) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000238813.95035.1b · Cited by 372
Aliprantis, A. O., Ueki, Y., Sulyanto, R., Park, A., Sigrist, K. S., Sharma, S. M., Ostrowski, M. C., Olsen, B. R., & Glimcher, L. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35711 · Cited by 350
Rheumatoid arthritis: regulation of synovial inflammation
Sweeney, S. E., & Firestein, G. S. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00259-0 · Cited by 318
Josien, R., Wong, B. R., Li, H.-L., Steinman, R. M., & Choi, Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2562 · Cited by 317
Smahi, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2371 · Cited by 300
Gut, inflammation and osteoporosis: Basic and clinical concepts
Tilg, H., Moschen, A. R., Kaser, A., Pines, A., & Dotan, I. (2008) · Gut · doi:10.1136/gut.2006.117382 · Cited by 292
Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.
Pincus, T., Yazıcı, Y., Sokka, T., Aletaha, D., & Smolen, J. S. (2003) · PubMed · Cited by 291
Matmati, M., Jacques, P., Maelfait, J., Verheugen, E., Kool, M., Sze, M., Geboes, L., Louagie, E., Guire, C. M., Vereecke, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.874 · Cited by 290
Abu-Amer, Y., Ross, F. P., Edwards, J., & Teitelbaum, S. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119679 · Cited by 289
Self-citationThe IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
Novack, D. V., Yin, L., Hagen-Stapleton, A., Schreiber, R. D., Goeddel, D. V., Ross, F. P., & Teitelbaum, S. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030116 · Cited by 281
Osteoporosis, genetics and hormones
Rizzoli, R., Bonjour, J., & Ferrari, S. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260079 · Cited by 274
The IκB kinase – a bridge between inflammation and cancer
Karin, M. (2008) · Cell Research · doi:10.1038/cr.2008.30 · Cited by 259
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
NF-κB modulators in osteolytic bone diseases
Xu, J., Wu, H. F., Ang, E. S. M., Yip, K., Woloszyn, M., Zheng, M. H., & Tan, R. X. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.007 · Cited by 229
Laplantine, E., Fontan, E., Chiaravalli, J., Lopez, T., Lakisic, G., Véron, M., Agou, F., & Israël, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.241 · Cited by 201
Dai, S., Hirayama, T., Abbas, S., & Abu-Amer, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400258200 · Cited by 196
Self-citationDeubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB
Jono, H., Lim, J. H., Chen, L.-F., Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., & Li, J.-D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406638200 · Cited by 179
The Association of Notch2 and NF-κB Accelerates RANKL-Induced Osteoclastogenesis
Fukushima, H., Nakao, A., Okamoto, F., Shin, M., Kajiya, H., Sakano, S., Bigas, A., Jimi, E., & Okabe, K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00299-08 · Cited by 178
NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism
Yao, Z., Xing, L., & Boyce, B. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38716 · Cited by 163
The antioxidant effects of statins
Davignon, J., Jacob, R. F., & Mason, R. P. (2004) · Coronary Artery Disease · doi:10.1097/01.mca.0000131573.31966.34 · Cited by 161
Inflammaging: The driving force in osteoporosis?
Lencel, P., & Magne, D. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.09.023 · Cited by 161
RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation
Vaira, S., Johnson, T., Hirbe, A. C., Alhawagri, M., Anwisye, I., Sammut, B., O'Neal, J., Zou, W., Weilbaecher, K. N., Faccio, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708576105 · Cited by 160
Characterization of the IκB-kinase NEMO Binding Domain
May, M. J., Marienfeld, R. B., & Ghosh, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206494200 · Cited by 152
Milward, M. R., Chapple, I., Wright, H. J., Millard, J. L., Matthews, J. B., & Cooper, P. R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03342.x · Cited by 146
Ciani, B., Layfield, R., Cavey, J. R., Sheppard, P. W., & Searle, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307416200 · Cited by 141
Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Ohmae, T., Sakamoto, K., Nakagawa, H., Ogura, K., & Omata, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2681 · Cited by 132
McCormick, R. K. (2007) · PubMed · Cited by 125
Mansour, S., Woffendin, H. B., Mitton, S. G., Jeffery, I., Jakins, T., Kenwrick, S., & Murday, V. A. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(2001)9999:9999<::aid-ajmg1155>3.0.co;2-y · Cited by 120
Choi, M., Rolle, S., Wellner, M., Cardoso, M. C., Scheidereit, C., Luft, F. C., & Kettritz, R. (2003) · Blood · doi:10.1182/blood-2002-09-2960 · Cited by 116
Required and nonessential functions of nuclear factor-kappa B in bone cells
Boyce, B. F., Xing, L., Franzoso, G., & Siebenlist, U. K. (1999) · Bone · doi:10.1016/s8756-3282(99)00105-2 · Cited by 114
Particle disease. A comprehensive theory of periprosthetic osteolysis: a review.
Gallo, J., Kamínek, P., Ticha, V., Řiháková, P., & Ditmar, R. (2002) · Biomedical Papers · doi:10.5507/bp.2002.004 · Cited by 111
The Anti-Inflammatory Role of Vitamin E in Prevention of Osteoporosis
Shuid, A. N., Norazlina, M., Norliza, M., & Nirwana, S. I. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2012/142702 · Cited by 101
Direct Inhibition of NF-κB Blocks Bone Erosion Associated with Inflammatory Arthritis
Clohisy, J. C. F., Roy, B. C., Biondo, C., Frazier, E. P., Willis, D., Teitelbaum, S. L., & Abu‐Amer, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5547 · Cited by 96
Self-citationRANKL and RANK as novel therapeutic targets for arthritis
Nakashima, T., & Penninger, J. M. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00016 · Cited by 96
Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α
Chaisson, M. L., Branstetter, D. G., Derry, J. M. J., Armstrong, A. P., Tometsko, M. E., Takeda, K., Akira, S., & Dougall, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406392200 · Cited by 95
Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species
Moon, H., Kim, S. E., Yun, Y.-P., Hwang, Y., Bang, J. B., Park, J.-H., & Kwon, I. K. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.11.067 · Cited by 93
The Zinc Finger of NEMO Is a Functional Ubiquitin-binding Domain
Cordier, F., Grubisha, O., Traincard, F., Véron, M., Delepierre, M., & Agou, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806655200 · Cited by 91
Essential role of T cell NF-kappa B activation in collagen-induced arthritis.
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · PubMed · Cited by 88
Smith, C., Andreakos, E., Crawley, J. B., Brennan, F. M., Feldmann, M., & Foxwell, B. M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5895 · Cited by 87
Inflammation-Induced Bone Loss: Can it Be Prevented?
Romas, E., & Gillespie, M. T. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.07.004 · Cited by 87
Role of IKKγ/NEMO in Assembly of the IκB Kinase Complex
Li, X., Fang, X., & Gaynor, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008353200 · Cited by 83
Schett, G. A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2166 · Cited by 82
Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency
Kawai, T., Nishikomori, R., & Heike, T. (2012) · Allergology International · doi:10.2332/allergolint.12-rai-0446 · Cited by 77
NEMO/IKKγ: linking NF-κB to human disease
Courtois, G., Smahi, A., & Israël, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02154-2 · Cited by 77
Fan, C., Li, Q., Zhang, Y., Liu, X., Luo, M., Abbott, D., Zhou, W., & Engelhardt, J. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17337 · Cited by 76
Essential Role of T Cell NF-κB Activation in Collagen-Induced Arthritis
Seetharaman, R., Mora, A. L., Nabozny, G. H., Boothby, M. R., & Chen, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1577 · Cited by 76
Tas, S. W., de Jong, E. C., Hajji, N., May, M. J., Ghosh, S., Vervoordeldonk, M. J., & Tak, P. P. (2005) · European Journal of Immunology · doi:10.1002/eji.200425956 · Cited by 72
NF-κB Inhibition Protects against Tumor-Induced Cardiac Atrophy in Vivo
Wysong, A. S., Couch, M. E., Shadfar, S., Li, L., Rodriguez, J., Asher, S. A., Yin, X., Gore, M. R., Baldwin, A., Patterson, C., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.009 · Cited by 71
Soysa, N. S., Alles, N., Weih, D., Lovas, A., Mian, A. H., Shimokawa, H., Yasuda, H., Weih, F., Jimi, E., Ohya, K., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091030 · Cited by 70
Ting, A. Y., & Endy, D. (2002) · Science · doi:10.1126/science.1079331 · Cited by 67
IKKβ activation is sufficient for RANK-independent osteoclast differentiation and osteolysis
Otero, J. E., Dai, S., Alhawagri, M., Darwech, I., & Abu‐Amer, Y. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4 · Cited by 62
Self-citationMechanisms of bone loss in rheumatoid arthritis
Findlay, D. M., & Haynes, D. R. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0412-z · Cited by 58
Huang, G. T. ‐., Zhang, H.-B., Dang, H. N., & Haake, S. K. (2004) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.10.003 · Cited by 58
de Oliveira, R. R., Novaes, A. B., Garlet, G. P., de Souza, R. F., Taba, M., Sato, S., de Souza, S. L. S., Palioto, D. B., Grisi, M. F. M., & Feres, M. (2010) · Lasers in Medical Science · doi:10.1007/s10103-010-0864-z · Cited by 56
Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo
Ni, C.-Y., Wu, Z., Florence, W. C., Parekh, V. V., Arrate, M. P., Pierce, S. E., Schweitzer, B. L., Kaer, L. V., Joyce, S., Miyamoto, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7107 · Cited by 55
A Novel Ubiquitin-like Domain in IκB Kinase β Is Required for Functional Activity of the Kinase
May, M. J., Larsen, S. E., Shim, J., Madge, L. A., & Ghosh, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408579200 · Cited by 55
Clohisy, J. C. F., Yamanaka, Y., Faccio, R., & Abu‐Amer, Y. (2006) · Journal of Orthopaedic Research® · doi:10.1002/jor.20184 · Cited by 54
Self-citationPermaul, P., Narla, A., Hornick, J. L., & Pai, S. (2009) · Immunologic Research · doi:10.1007/s12026-008-8085-2 · Cited by 52
Otero, J. E., Dai, S., Foglia, D., Alhawagri, M., Vacher, J., Pasparakis, M., & Abu‐Amer, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800434200 · Cited by 51
Self-citationCytokine inhibitors in the treatment of rheumatoid arthritis
Gabay, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.2.135 · Cited by 51
A novel series of potent and selective IKK2 inhibitors
Bingham, A. H. A., Davenport, R. J., Gowers, L., Knight, R. L., Lowe, C. E., Owen, D. A., Parry, D. M., & Pitt, W. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.047 · Cited by 48
The molecular pathogenesis of Paget disease of bone
Layfield, R. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000464 · Cited by 46
Gautheron, J., & Courtois, G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0404-9 · Cited by 46
Constitutively Active Canonical NF-κB Pathway Induces Severe Bone Loss in Mice
Otero, J. E., Chen, T., Zhang, K., & Abu‐Amer, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038694 · Cited by 36
Self-citationIKKβ as a target for treatment of inflammation induced bone loss
Ruocco, M. G., & Karin, M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042721 · Cited by 35
Inflammation, cancer, and bone loss
Abu‐Amer, Y. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.007 · Cited by 35
Self-citationSugiyama, T. (2001) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740170046 · Cited by 35
Inflammatory Diseases: Is Ubiquitinated NEMO at the Hub?
Burns, K., & Martinon, F. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.040 · Cited by 34
Kubota, T., Hoshino, M., Aoki, K., Ohya, K., Komano, Y., Nanki, T., Miyasaka, N., & Umezawa, K. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2298 · Cited by 32
Advances in Osteoclast Differentiation and Function
Abu‐Amer, Y. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008054863808 · Cited by 29
Self-citationDarwech, I., Otero, J. E., Alhawagri, M., & Abu‐Amer, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121533 · Cited by 29
Self-citationHay, R. T. (2004) · Nature Cell Biology · doi:10.1038/ncb0204-89 · Cited by 27
Ubiquitin-mediated signalling and Paget's disease of bone
Layfield, R., & Shaw, B. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s5 · Cited by 26
Polyubiquitination Events Mediate Polymethylmethacrylate (PMMA) Particle Activation of NF-κB Pathway
Yamanaka, Y., Karuppaiah, K., & Abu‐Amer, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223669 · Cited by 24
Self-citationAntibacterial and Anti-inflammatory Activities of 4-Hydroxycordoin: Potential Therapeutic Benefits
Feldman, M., Tanabe, S., Epifano, F., Genovese, S., Curini, M., & Grenier, D. (2010) · Journal of Natural Products · doi:10.1021/np100547b · Cited by 22
Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy
Ruocco, M. G., & Karin, M. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_16 · Cited by 18
Alhawagri, M., Yamanaka, Y., Ballard, D. W., Oltz, E. M., & Abu‐Amer, Y. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21555 · Cited by 13
Self-citationTherapeutic approaches in bone pathogeneses: targeting the IKK/NF-κB axis
Abu‐Amer, Y., & Faccio, R. (2006) · Future Rheumatology · doi:10.2217/17460816.1.1.133 · Cited by 12
Self-citation
Cited by
Cheng, C.-H., Chen, L.-R., & Chen, K.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031376 · Cited by 595
Wang, X., Chen, B., Sun, J., Jiang, Y., Zhang, H., Zhang, P., Fei, B., & Xu, Y. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.005 · Cited by 113
Lin, W., Li, Y., Qiu, C., Zou, B., Gong, Y., Zhang, X., Tian, D., Sherman, W., Sanchez, F., Wu, D., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1298 · Cited by 46
Zeng, J., Guo, J., Sun, Z., Deng, F., Ning, C., & Xie, Y. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.03.008 · Cited by 46
Wong, S.-W., Huang, B.-W., Hu, X., Ho Kim, E., Kolb, J. P., Padilla, R. J., Xue, P., Wang, L., Oguin, T. H., Miguez, P. A., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0341-6 · Cited by 42
Metadata
- Authors
- Abu-Amer, Y.
- Venue
- Osteoporosis International
- Published
- 2013-03-07
- Volume
- 24
- Issue
- 9
- Pages
- 2377-2386
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2085536927
- Cited by
- 340
- References
- 131
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.